Skip to content

Clinical trials

Observational Bipolar Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Observational Clear all

346 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20024
20031
20047
200512
20069
200718
200812
200913
201014
201118
201212
201317
201411
201517
201618
201711
201811
201910
202019
202111
202215
202311
202422
202527
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed199
Unknown status55
Recruiting41
Not yet recruiting14
Terminated13
Active, not recruiting9
Withdrawn7
Enrolling by invitation6
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca26
National Institute of Mental Health (NIMH)19
Massachusetts General Hospital11
Shanghai Mental Health Center7
Northwestern University6
University Hospitals Cleveland Medical Center5
University of Texas Southwestern Medical Center5
Central South University4
GlaxoSmithKline4
Mclean Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder346
Schizophrenia82
Major Depressive Disorder77
Mood Disorders38
Psychotic Disorders36
Depressive Disorder25
Mental Disorders23
Anxiety Disorders18
Attention Deficit Disorder with Hyperactivity15
Mania15

Trials

Showing 26 to 50 of 346. Each trial links to its page on Pharma Observatory.

246 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.